ALAIN01—Alemtuzumab in autoimmune inflammatory neurodegeneration: mechanisms of action and neuroprotective potential
Crossref DOI link: https://doi.org/10.1186/s12883-016-0556-9
Published Online: 2016-03-10
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ruck, Tobias
Afzali, Ali Maisam
Lukat, Karl-Friedrich
Eveslage, Maria
Gross, Catharina C.
Pfeuffer, Steffen
Bittner, Stefan
Klotz, Luisa
Melzer, Nico
Wiendl, Heinz
Meuth, Sven G.